Based on the induction of cell apoptosis and inhibition of cell proliferation by sulindac, we hypothesize that these functions of sulindac may be associated with increased JNK1 phosphorylation and suppression of β-catenin in human prostate cancer cells. The gene discussed is MAPK8; the disease is prostate cancer.